Diseases [C] » Digestive System Diseases [C06] » Liver Diseases » Hepatitis
Description
INFLAMMATION of the LIVER. MeSH
Hierarchy View
Subtype Terms (4)
Hepatitis, Alcoholic
44 drugs (26 approved, 18 experimental)
Hepatitis, Chronic
21 drugs (13 approved, 8 experimental)
Hepatitis, Viral, Human
10 drugs (5 approved, 5 experimental)
Approved Indicated Drugs (3)
Phase 4 Indicated Drugs (16)
Phase 3 Indicated Drugs (2)
Phase 2 Indicated Drugs (9)
Phase 1 Indicated Drugs (5)
Other Experimental Indicated Drugs (5)
Organization Involved with Phase 4 Indications (421)
Ahvaz Jundishapur University of Medical Sciences
Alaska Native Tribal Health Consortium
Alexander von Humboldt Association
American Research Corporation (ARC)
Asian Institute Of Medical Sciences
Asian-Pacific Alliance of Liver Disease, Beijing
Baqiyatallah Medical Sciences University
Beijing Kawin Technology Share-Holding Co., Ltd.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
California HIV/AIDS Research Program
Canadian Institutes of Health Research (CIHR)
Case Western Reserve University
Center For Hepatitis C, Atlanta, GA
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention, China
Centre for Infectious Disease Research in Zambia (CIDRZ)
Chacha Nehru Bal Chikitsalaya, New Delhi
Children's National Medical Center
China Academy of Chinese Medical Sciences
China National Biotec Group Co., Ltd
Chinese Academy of Medical Sciences
Chinese University of Hong Kong
Christian Medical College, Vellore, India
Chronic Liver Disease Foundation
Clinical Pharmacology of Miami
Community Research Initiative of New England
Daewoong Pharmaceutical Co. LTD.
Dalin Tzu Chi General Hospital
Department of Health, United Kingdom
Federal University of Health Science of Porto Alegre
Federal University of Rio de Janeiro
Fifth Hospital of Shijiazhuang City
First People's Hospital of Foshan
First People's Hospital, Shunde China
French National Agency for Research on AIDS and Viral Hepatitis
Gottfried Wilhelm Leibniz Universität Hannover
Govind Ballabh Pant Institute of Postgraduate Medical Education and Research
Hamadan University of Medical Science
Hannover Clinical Trial Center GmbH
Hepatobiliary Disease Hospital of Jilin Province, Jilin, China
HIV-NAT Thai Red Cross AIDS Research Center
Hospital Federal de Bonsucesso
Hospital Universitario Fundación Alcorcón
Hospital Universitario San Cecilio
Huai'an No. 4 People's Hospital
Huazhong University of Science and Technology
Hubei University of Chinese Medicine
Huizhou People's Central Hospital
Humanity & Health Research Centre
Icahn School of Medicine at Mount Sinai
Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)
International Antiviral Therapy Evaluation Center (IATEC)
International Center for Diarrheal Disease Research
International Society for Infectious Diseases
Iranian Blood Transfusion Research Center
Jiangsu Chia-tai Tianqing Pharmaceutical Co.,Ltd
King Faisal Specialist Hospital
Major Science and Technology Special Project of China Twelfth-Five-Year Project
Medical University of South Carolina
Nanyang Technological University
National Cheng Kung University
National Health and Family Planning Commission, P.R.China
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
National Institute of Mental Health (NIMH)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute on Drug Abuse (NIDA)
National Institutes of Health (NIH)
National University of Singapore
New York Presbyterian Hospital
Oregon Health and Science University
Orlando Clinical Research Center
People's Liberation Army of China
Pontificia Universidad Catolica de Chile
Postgraduate Institute of Medical Education and Research
Principal SIMS/Services hospital lahore
Qingdao Infectious Diseases Hospital
Rajiv Gandhi University of Health Sciences
Research Foundation for Mental Hygiene, Inc.
SC Liver Research Consortium, LLC
Second Military Medical University
Services Institute of Medical Sciences, Pakistan
Shahid Beheshti University of Medical Sciences
Shandong University of Traditional Chinese Medicine
Shanghai University of Traditional Chinese Medicine
Shenzhen Kangtai Biological Products Co., LTD
Shenzhen Third People's Hospital
Shineway Pharmaceutical Co.,Ltd
Singapore Clinical Research Institute
Sociedad Andaluza de Enfermedades Infecciosas
Southern California Research Center
State University of New York, Syracuse
Taichung Veterans General Hospital
Taipei Veteran General hospital
The Fifth Hospital of Shijiazhuang
The Fifth People's Hospital of Suzhou
The University of Texas, Dallas
Tropical Diseases Hospital, Ho Chi Minh City
Tung's Taiching MetroHarbor Hospital
Universidad Autonoma de Barcelona
University of Alabama, Birmingham
University of British Columbia
University of California, Los Angeles
University of California, San Diego
University of California, San Francisco
University of Colorado, Denver
University of Medicine and Dentistry of New Jersey
University of Modena and Reggio Emilia
University of North Carolina at Chapel Hill
University of Roma La Sapienza
University of Southern California
University of Texas at Houston
University of Texas, San Antonio
University of the Witwatersrand
Virginia Commonwealth University
Western Hospital, Footscray, Victoria. Australia
Wilhelminenspital der Stadt Wien
Xiamen Center for Disease Control and Prevention
Yassin Abdelghaffar Charity Center for Liver Disease and Research
Yassin Abdel Ghaffar Charity Center for Liver Disease and Research
Organization Involved with Phase 3 Indications (164)
Advanced Medical Services GmbH
Ascletis Pharmaceuticals Co., Ltd.
Azienda Ospedaliera S Giovanni Battista
Bangabandhu Sheikh Mujib Medical University
Boryung Pharmaceutical Company
Casa Sollievo della Sofferenza IRCCS
CIHR Canadian HIV Trials Network
Clinical Research Organization, Dhaka, Bangladesh
Clinique Medicale L'Actuel, Que
Dynavax Technologies Corporation
Hopital Principal de Dakar Senegal
Hospital Universitario Virgen Macarena
Institute Of Cardiology & Internal Diseases, Kazakhstan
Institute of Liver and Biliary Sciences, India
Jiangsu Hansoh Pharmaceutical Co., Ltd.
Kazan State Medical University
Kermanshah University of Medical Sciences
Kirov Military Medical Academy
LLC Medical Company Hepatolog, Samara, Russia
Medical Research Council, South Africa
Minnesota Veterans Medical Research and Education Foundation
M V Hospital & Research Center, Lucknow
Nanjing Sanhome Pharmaceutical, Co., Ltd.
National Center for Research Resources (NCRR)
National Heart, Lung, and Blood Institute (NHLBI)
National Hepatology & Tropical Medicine Research Institute
Rajasthan University of Health Sciences
Regional State Healthcare Institution Smolensk Regional Clinical Hospital
RojanPharma Pharmaceutical Company
Sanjay Gandhi Postgraduate Institute of Medical Sciences
Smolensk State Medical Academy
Society of Friends of Liver Patients in the Arab World (SLPAW)
Southern California Institute for Research and Education
St. Petersburg City Health Department
TaiwanJ Pharmaceuticals Co., Ltd
TCM Biotech International Corp.
Tianjin Second People's Hospital
Tianyi medical instruments limited company
University of California, Irvine
University of Naples Frederico II
University of Picardie Jules Verne
Vaccination and Travel Medicine Centre Poliklinika II
V.I. Razumovsky, Healthcare Committee at the Administration of Saratov City Municipal District
Vita-Salute University of Milano. Italy
Organization Involved with Phase 2 Indications (212)
All India Institute of Medical Sciences
Antipodean Pharmaceuticals, Inc.
Atlanta Gastroenterology Associates
Australian Respiratory and Sleep Medicine Institute
Azienda Ospedaliera Universitaria Policlinico
Badalona Hospital Germans Trias i Pujol
Beijing Clinical Service Center
Cantonal Hospital of St. Gallen
Cell Therapy And Technology, S.a. De C.v.
Centers for Disease Control and Prevention, Division of Reproductive Health
Chao Family Comprehensive Cancer Center
CHA Vaccine Institute Co., Ltd.
Clinica Universidad de Navarra
Daiwa Pharmaceutical Corporation
Florida Center for Gastroenterology
Fondazione Italiana Diabete Onlus
Fundacion de Investgacion de Diego
German Center for Infection Research
Gruppo Italiano Malattie EMatologiche dell'Adulto
Guangzhou Baidi Biotechnology Co., Ltd
Guangzhou Pharmaceucal Company Limited
Guangzhou Yipinhong Pharmaceutical CO.,LTD
Hospital de Sant Pau i Santa Tecla de Tarragona
Huntington Medical Research Institutes
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Institut National de la Santé Et de la Recherche Médicale, France
Japan Agency for Medical Research and Development
Los Angeles Biomedical Research Institute
Mashhad University of Medical Sciences
Metropolitan Liver Diseases/ Gastroenterology Center
Moscow Regional Resarch adn Clinical Institute
Nashville Medical Research Institute
National Center for Complementary and Integrative Health (NCCIH)
National Center for Global Health and Medicine
National Institute of Nursing Research (NINR)
New England Research Institutes
Office of Dietary Supplements (ODS)
Pharmaceutical Research Associates, Inc. (PRA)
Razi Vaccine and Serum Research Institute
Russian Academy of Medical Sciences
Second People's Hospital of Yunnan Province
Shanghai HEP Pharmaceatical Co., Ltd.
Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
Organization Involved with Phase 1 Indications (59)
AIDS Research Consortium of Atlanta
American Association for Cancer Research
Maharaj Nakorn Chiang Mai Hospital
National Institute for Health Research, United Kingdom
Nucorion Pharmaceuticals, Inc.
Organization Involved with Other Experimental Indications (51)
American College of Gastroenterology
Asfendiyarov Kazakh National Medical University
Corporal Michael J. Crescenz VA Medical Center
Eastern Hepatobiliary Surgery Hospital
Hospital General Dr. Manuel Gea Gonzalez
Hunan University of Traditional Chinese Medicine
Hierarchy Tree View
UMLS Data
YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.